School of Medicine
Showing 101-200 of 618 Results
-
Leonor García-Bayona
Assistant Professor of Microbiology and Immunology
Current Research and Scholarly InterestsThe human microbiome is evolving rapidly (i.e. over our lifetimes) following changes in modern lifestyles, especially in industrialized countries. The García-Bayona lab seeks to understand how horizontal gene transfer shapes interactions within the human intestinal microbiota and what the implications of this widespread phenomenon are for community properties relevant to human health (for example, the ability of the gut community to recover after antibiotic treatment). There is currently only a superficial understanding of the different cellular roles of most exchanged genes, the mechanisms governing their spread and their effect community dynamics. Our lab works on bridging the existing gap between the current systems-level observational studies and a mechanistic understanding through bacterial genetics and physiology. We take a bottom-up approach (from genes to communities), incorporating genetics, metagenomics, population analyses and experimental evolution in tractable bacterial consortia.
-
Manuel Garcia-Careaga
Current Research and Scholarly InterestsGastroenterology, liver disease in cystic fibrosis patients, percutaneous gastrostomy tube in pediatric population, inflamatory bowel disease, failure to thrive
-
Christopher Gardner
Rehnborg Farquhar Professor
Current Research and Scholarly InterestsThe role of nutrition in individual and societal health, with particular interests in: plant-based diets, differential response to low-carb vs. low-fat weight loss diets by insulin resistance status, chronic disease prevention, randomized controlled trials, human nutrition, community based studies, Community Based Participatory Research, sustainable food movement (animal rights and welfare, global warming, human labor practices), stealth health, nutrition policy, nutrition guidelines
-
Michael J. Gardner, MD
Hatim and Durriya Tyabji Endowed Professor
Current Research and Scholarly InterestsDr. Gardner’s investigative program during his academic career has involved a two-pronged approach, including both clinical and basic research. Prior to joining the Orthopaedic Department at Stanford, he was the Director of the Orthopaedic Trauma Research Program at Washington University School of Medicine in St. Louis, MO. During his tenure as Director, he organized a highly productive and efficient research program. This resulted in publication of many scientific manuscripts, and numerous ongoing multicenter and single center trials that remain active.
Throughout his career, he has published over 100 peer-reviewed original scientific manuscripts, in addition to over 50 invited manuscripts, brief reports, and review papers. He has edited two published text books, is currently editing two more books, and has co-authored over 30 book chapters. His goals include continuing to be highly active in both clinical and basic research, and to continue attaining grant funding to support this work. -
Rebecca M. Gardner
Ph.D. Student in Epidemiology and Clinical Research, admitted Autumn 2022
BioMy research interests are in maternal nutrition and well-being, with a current focus on hyperemesis gravidarum (HG)—severe nausea and vomiting during pregnancy that often causes significant maternal undernutrition and poor antepartum and postpartum mental health, and is the leading cause of hospitalization in early pregnancy. I study HG from several angles: the environmental exposures that may exacerbate it, including ambient air pollution and wildfire smoke, and whether these contribute to HG-related hospitalization; and its downstream consequences for both mothers and children, including hypertensive disorders of pregnancy such as preeclampsia, preterm birth, and neurodevelopmental conditions in childhood such as autism. More broadly, I am interested in hypertensive disorders of pregnancy, preterm birth, and gestational diabetes, and their subsequent effects on offspring. Methodologically, I am drawn to applying causal inference methods traditionally used in economics to questions in public health.
Before starting a PhD, I was a biostatistician in the Quantitative Sciences Unit at Stanford for four years where I co-authored over thirty publications, collaborating with clinicians on various domains including developmental behavioral pediatrics, reproductive endocrinology & infertility, oncology, and clinical trials. I completed my MS in Statistics at Brigham Young University in 2016, where I collaborated with cardiologists to develop a new approach to diagnose rheumatic heart disease in pediatric patients in Samoa for my Master's thesis. -
Joseph Garner
Professor of Comparative Medicine and, by courtesy, of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsThe medical research community has long recognized that "good well-being is good science". The lab uses an integrated interdisciplinary approach to explore this interface, while providing tangible deliverables for the well-being of human patients and research animals.
-
Matthias Garten
Assistant Professor of Microbiology and Immunology and of Bioengineering
Current Research and Scholarly InterestsWith a creative, collaborative, biophysical mindset, we aim to understand the ability non-model organisms to interface with environment to a point at which we can exploit the mechanisms finding cures against diseases and use the mechanisms as tools that we can use to engineer the environment. By developing approaches that allow a quantitative understanding and manipulation of molecular transport our research makes non-model organisms accessible to researchers and engineers.
Specifically, we are studying how the malaria parasite takes control over red blood cells. By learning the biophysical principles of transport in between the host and the parasite we can design ways to kill the parasite or exploit it to reengineer red blood cells. The transport we study is broadly encompassing everything from ions to lipids and proteins. We use variations of quantitative microscopy and electrophysiology to gain insight into the unique strategies the parasite evolved to survive. -
Olya Gary
Web Designer 3, OHNS/Otolaryngology/Head & Neck Surgery
Current Role at StanfordAs a senior web designer at Otolaryngology — Head & Neck Surgery Department and a member of the OHNS web team, I support the entire department web presence: http://med.stanford.edu/ohns.html.
I oversee a large number of projects related to the main OHNS site, research lab Wordpress sites, work on the website updates, and create visuals and photographs highlighting the department teams and places. I work with a large number of the department team members - from the administrative staff to the faculty members. -
Sergios Gatidis
Associate Professor of Radiology (Pediatric Radiology)
BioDr. Gatidis completed his medical training at the University of Tuebingen / Germany and received his Diploma in Mathematics from from the Universities of Tuebingen and Hagen / Germany. His research is focused on on methods and applications of machine learning for medical data analysis and translation of AI into clinical practice.
-
Brice Gaudilliere
Professor of Anesthesiology, Perioperative and Pain Medicine (MSD) and, by courtesy, of Pediatrics (Neonatology)
Current Research and Scholarly InterestsThe advent of high dimensional flow cytometry has revolutionized our ability to study and visualize the human immune system. Our group combines high parameter mass cytometry (a.k.a Cytometry by Time of Flight Mass Spectrometry, CyTOF), with advanced bio-computational methods to study how the human immune system responds and adapts to acute physiological perturbations. The laboratory currently focuses on two clinical scenarios: surgical trauma and pregnancy.
-
Dyani Gaudilliere
Clinical Associate Professor, Surgery - Plastic & Reconstructive Surgery
BioDr. Dyani Gaudilliere specializes in Dental Surgery and Oral Oncology in a hospital setting. As a hospital dentist she performs surgical treatment of infection and trauma to the teeth and supporting alveolar bone. She also performs medically necessary dental clearance and extractions in the context of larger medical conditions, such as cardiac disease, joint replacement, or organ transplantation. As an oral oncologist, she specializes in surgical dental treatment prior to, during, and following radiation therapy and chemotherapy.
-
Benny Gavi, MD, MTS
Clinical Assistant Professor, Medicine
Current Research and Scholarly InterestsHospitalist Medicine
Medicine Consultation
Quality Improvement
Medical Ethics
Organizational Ethics
Medical Humanities -
Charles Gawad
Associate Professor of Pediatrics (Hematology/Oncology)
BioOur lab works at the interface of biotechnology, computational biology, cellular biology, and clinical medicine to develop and apply new tools for characterizing genetic variation across single cells within a tissue with unparalleled sensitivity and accuracy. We are focused on applying these technologies to study cancer clonal evolution while patients are undergoing treatment with the aim of identifying cancer clonotypes that are associated with resistance to specific drugs so as to better understand and predict treatment response. We are also applying these methods to understand how more virulent pathogens emerge from a population of bacteria or viruses with an emphasis on developing a deeper understanding of how antibiotic resistance develops.
-
Michael W. Gaynon, MD
Clinical Professor, Ophthalmology
Current Research and Scholarly Interests-Retinal Vascular Disease
-Angiogenesis
-Retinopathy of Prematurity
-Sustained Release Drug Delivery Systems -
Sharon Markham Geaghan
Associate Professor of Pathology at the Stanford University Medical Center, Emerita
Current Research and Scholarly InterestsPediatric Hematopathology, Pediatric Laboratory Medicine and Pathology
-
Benedikt Geier
Postdoctoral Scholar, Infectious Diseases
BioB.Sc. Biology, Ludwig Maximilian University (LMU), Munich/Germany (2013)
M.Sc. Biology and bioimaging, Ludwig Maximilian University (LMU), Munich/Germany (2015)
Ph.D., Animal-Microbe Symbioses, Max Planck Institute for Marine Microbiology in Bremen/Germany (2020)
Benedikt joined the Amieva Lab from Germany in 2022. During his B.Sc. and M.Sc. programs in zoology, he became fascinated with 3D imaging approaches to study small animal microanatomy. He spent his PhD developing in situ imaging approaches to study deep-sea symbioses and fell in love with studying host-microbe interactions. In the Amieva Lab, Benedikt will advance his previously developed correlative chemical imaging techniques to resolve metabolic and cellular interactions that drive H. pylori pathogenesis in the gastric glands.
More about Benedikt's transition from deep-sea microbiology into infectious disease research can be found here:
https://scopeblog.stanford.edu/2022/08/24/unconventional-paths-deep-sea-to-the-stomach/ -
Pascal Geldsetzer
Assistant Professor of Medicine (Primary Care and Population Health) and, by courtesy, of Epidemiology and Population Health
BioPascal Geldsetzer is an Assistant Professor of Medicine in the Division of Primary Care and Population Health and, by courtesy, in the Department of Epidemiology and Population Health. He is also affiliated with the Phil & Penny Knight Initiative for Brain Resilience at the Wu Tsai Neurosciences Institute, Department of Biomedical Data Science, Department of Health Policy, and the Stanford Center for Population Health Sciences.
His research focuses on identifying and evaluating the most effective interventions for improving health at older ages. In addition to leading several randomized trials, his methodological emphasis lies in the use of natural experiments to ascertain causal effects in large observational datasets, particularly in electronic health record data. He has won an NIH New Innovator Award (in 2022), a Chan Zuckerberg Biohub investigatorship (in 2022), and three NIH R01 grants as Principal Investigator (in 2023 and 2024). In 2026, he was named one of the 100 most influential people in health and medicine globally by TIME Magazine. -
Margarita Geleta
Graduate, Biomedical Data Science
BioMargarita Geleta is a computer science PhD Candidate at University of California, Berkeley (major in Artificial Intelligence and minor in Human-Computer Interaction), and a visiting graduate student at Stanford University. Ms. Geleta received her M.S. in computer science at University of California, Berkeley.
-
Linda N. Geng, MD, PhD
Clinical Associate Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsMy scholarly focus is on puzzling and complex conditions. Our work aims to improve patients' diagnostic journeys, characterize poorly understood diseases, discover biological mechanisms, find treatments, improve care models, and reach communities in need.
With the COVID pandemic, the puzzling and complex illness of Long COVID or post-acute COVID-19 syndrome (PACS) emerged. Together with a multidisciplinary group of physicians and researchers, we launched a program here at Stanford to advance the care and understanding of Long COVID. Our goal is to better understand the natural history, clinical symptomatology, immunological response, risk factors, and subtypes of Long COVID. We are also actively assessing treatment strategies for Long COVID and developing care pathways and tools for clinicians to help their patients with this and other related infection-associated chronic illnesses. -
Grace Gengoux, PhD, BCBA-D
Clinical Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
Current Research and Scholarly InterestsDr. Grace Gengoux is Director of the Autism Intervention Clinic and leads an autism intervention research program focused on developing and evaluating promising behavioral and developmental treatments for Autism Spectrum Disorder (ASD).
Dr. Gengoux is also Associate Chair for Faculty Engagement & Well-being and Department Well-being Director in the Department of Psychiatry and Behavioral Sciences, leading the department's Standing Well-being Advisory Committee. -
Jacqueline Genovese
Academic Prog Prof 3, School of Medicine - Biomedical Ethics
Current Role at StanfordExecutive Director of the Medicine & the Muse Program
LEAD Program for Residents, Mentor (2021-2024)
Member of Stanford School of Medicine Staff Collective
Steering Committee Member: Health Humanities Consortium (2019-2024)
Teaching Lead, War Literature & Writing class for military affiliated students
Co-teacher, War and Fiction for non military and military affiliated students (2017-2109)
Facilitator, Literature & Medicine Dinner & Discussion Series
Co-Lead: Frankenstein@200 2017-2018 Initiative
Member of Stanford Medicine Arts & Mindfulness Committee (Stanford Health) -
Mark Genovese
James W. Raitt M.D. Professor, Emeritus
Current Research and Scholarly InterestsClinical trials and interventions in the rheumatic diseases including Rheumatoid Arthritis,Systemic Lupus Erythematosus, Systemic Sclerosis, Osteoarthritis.
-
Michael Gensheimer, MD
Clinical Associate Professor, Radiation Oncology - Radiation Therapy
Current Research and Scholarly InterestsIn addition to my clinical research in head and neck and lung cancer, I work on the application of computer science and machine learning to cancer research. I develop tools for analyzing large datasets to improve outcomes and safety of cancer treatment. I developed a machine learning prognostic model using data from around 13,000 patients with metastatic cancer which performs better than traditional models and physicians [PubMed ID 33313792]. We recently completed a prospective randomized study in thousands of patients in which the model was used to help improve advance care planning conversations.
I also work on the methods underpinning observational and predictive modeling research. My open source nnet-survival software that allows use of neural networks for survival modeling has been used by researchers internationally. In collaboration with the Stanford Research Informatics Center, I examined how electronic medical record (EMR) survival outcome data compares to gold-standard data from a cancer registry [PubMed ID 35802836]. The EMR data captured less than 50% of deaths, a finding that affects many studies being published that use EMR outcomes data. -
Andrew Gentles
Associate Professor (Research) of Pathology, of Medicine (Computational Medicine) and, by courtesy, of Biomedical Data Science
Current Research and Scholarly InterestsComputational systems biology
-
Heather Gentner
Director of Finance and Administration (SoM), Stem Cell Bio Regenerative Med Institute
Current Role at StanfordI am the Director of Finance and Administration for the Institute for Stem Cell Biology and Regenerative Medicine (ISCBRM) in the School of Medicine. I oversee and carry out administrative and financial related functions for the department.
-
Paul George, MD, PhD
Associate Professor of Neurology and Neurological Sciences (Adult Neurology) and, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsDEVELOPMENT OF STROKE RECOVERY THERAPEUTICS:
Stroke is devastating to patients and their caregivers. We currently are investigating 3 neural repair approaches. The first focuses on developing a stroke recovery therapeutic based on an essential repair pathway and how it alters the immune response following stroke. The second utilizes implantable, conductive polymer devices to electrically manipulate the recovering nervous system to improve recovery and identify novel therapeutic targets. The final approach works to optimize stem cell therapeutics to enhance their ability to treat patients who have suffered from neural injury.
CONDUCTIVE BIOPOLYMER SYSTEMS FOR NEURAL RECOVERY AND STEM CELL MODULATION:
The George lab develops biomaterials to improve neural recovery in the peripheral and central nervous systems. By controlled release of drugs and molecules through biomaterials we can study the temporal effect of these neurotrophic factors on neural recovery and engineer drug delivery systems to enhance regenerative effects. By identifying the critical mechanisms for neural recovery, we are able to develop polymeric technologies for clinical translation in nerve regeneration. Recent work utilizes these novel conductive polymers to differentiate stem cells for therapeutic and drug discovery applications.
APPLYING ENGINEERING TECHNIQUES TO DETERMINE BIOMARKERS FOR STROKE DIAGNOSTICS:
The ability to create diagnostic assays and techniques enables us to understand biological systems more completely and improve clinical management. Previous work utilized mass spectroscopy proteomics to find a simple serum biomarker for TIAs (a warning sign of stroke). Our study discovered a novel candidate marker, platelet basic protein. Current studies are underway to identify further candidate biomarkers using transcriptome analysis. More accurate diagnosis will allow for aggressive therapies to prevent subsequent strokes. -
Marios Georgiadis
Instructor, Radiology
BioMarios is an Instructor of Neuroimaging in the Department of Radiology.
His research focuses mainly on studying brain microstructure using cutting edge imaging (advanced X-ray, MRI, optical, and spatial biology approaches), with a particular focus on Alzheimer's disease hippocampi, neurodegeneration, and a special interest in myelin and iron.
He is also actively involved in projects related to imaging and modeling brain trauma, exosome signatures of neurodegeneration, and imaging the brain using advanced forms of electron and light microscopy.
His current research is being supported by NIH, the Alzheimer's Association, the American Society of Neuroradiology, the National Alzheimer's Coordinating Center (NACC), and the Stanford ADRC.
Marios is a mechanical engineer by training (School of Mechanical Engineering, National Technical University of Athens, Greece). His thesis "Closed-loop force control of a haptic surgical simulator", was performed in the Control Systems Lab of Prof. Evangelos Papadopoulos.
In 2011 he obtained his MSc in Biomedical Engineering from ETH Zurich (Swiss Federal Institute of Technology). He performed his thesis in IBM Research on "Advanced pathology using the Microfluidic Probe", under Emmanuel Delamarche and Govind Kaigala, and was awarded the ETH medal for this work.
He completed his PhD in Bone Biomechanics in the lab of Prof. Ralph Muller in ETH Zurich, where he developed X-ray scattering-based methods to investigate bone microstructure in 3D, research that earned him the 2nd Student Award from the European Society for Biomechanics in 2015.
In 2016 he started using imaging methods to study brain microstructure, in the lab of Prof. Markus Rudin, in the Institute for Biomedical Engineering of ETH Zurich. There, he combined X-ray scattering with DTI, histology and CLARITY for studying rodent brain.
In 2017 he joined the MRI Biophysics group of Profs. Els Fieremans and Dmitry Novikov in New York University School of Medicine, to study human and mouse brain microstructure using X-ray scattering and diffusion MRI.
He is in the Translational Neuroimaging lab, headed by Dr Michael Zeineh, since 2019.
His research on myelin in mouse and human brain using X-ray scattering has been supported twice by the Swiss National Science Foundation. -
Daniel Aaron Gerber, MD
Clinical Associate Professor, Medicine - Cardiovascular Medicine
BioDr. Gerber is a critical care cardiologist and medical director of Stanford's cardiac ICU. He has dual subspecialty training in cardiovascular and critical care medicine and additional board certification in echocardiography. He completed his residency in internal medicine, fellowship in cardiovascular medicine, and an additional fellowship in critical care medicine at Stanford University and joined as faculty in 2021 as a Clinical Assistant Professor in the Department of Medicine’s Division of Cardiovascular Medicine.
Dr. Gerber manages the full spectrum of heart and vascular conditions with a focus on critically ill patients with life-threatening cardiovascular disease. He is active in medical education, teaching introductory echocardiography to Stanford medical students and residents, co-directing the Stanford Critical Care Medicine Critical Care Ultrasound Program, and lecturing nationally on critical care echocardiography and point-of-care ultrasonography at the Society of Critical Care Medicine’s annual congress. Finally, Dr. Gerber’s research interests focus on optimizing cardiac intensive care, including working with the Critical Care Cardiology Trials Network (CCCTN) - a national network of tertiary cardiac ICUs coordinated by the TIMI Study Group - and studying acute mechanical circulatory support techniques to improve patient outcomes and care processes. -
Yael Gernez
Clinical Associate Professor, Pediatrics - Immunology
BioMy clinic focuses on solving the molecular puzzles that underlie rare allergic and immunologic diseases to shed light on fundamental principles governing allergy, inflammation and immune system defects. My goal is to find better and safer therapies for my patients with rare diseases that include autoinflammation, autoimmunity and primary immune deficiency. It is important to highlight that every patient requires individualized therapeutic approaches based on their underlying genetic problem and the types and severity of their clinical manifestations. For some patients, a hematopoietic stem cell transplant (HSCT) is curative while for others, a targeted drug therapy, such as a biologic or small molecule agent, is most suitable. In some cases, a truly novel therapy may be required, .e.g., anti-sense oligonucleotide therapy to suppress aberrant gene splicing or adoptive cellular therapy. My passion is to provide the best personalized therapy for our patients with allergy and immunology diseases. This often requires performing very specialized functional assays and in some cases in enlisting laboratories with specific expertise or interest in particular genetic disorders.
-
Rabin Gerrah
Clinical Assistant Professor, Cardiothoracic Surgery
BioDr. Rabin Gerrah is a cardiothoracic surgeon and specializes in surgical treatment of heart diseases such as ischemic, valvular, structural and congenital heart diseases. He has been trained at Harvard University and Columbia University Hospitals. Dr. Gerrah has been involved in multiple medical research projects and has patented and developed innovative surgical devices and technologies.
-
Elias Roth Gerrick
Member, Maternal & Child Health Research Institute (MCHRI)
BioEli received his B.S. in Microbiology and Immunology from U.C. Irvine in 2013, where he worked in the lab of Dr. Celia Goulding. He earned his Ph.D. from Harvard University in 2018 in the lab of Dr. Sarah Fortune, where he studied post-transcriptional regulation of gene expression in Mycobacterium tuberculosis. Eli joined the Howitt lab at Stanford in the summer of 2018, where he is studying the influence of protozoan members of the microbiome on intestinal immunity.
-
Neil Gesundheit
George DeForest Barnett Founders Professor of Medicine and Professor (Teaching) of Medicine (Endocrinology)
Current Research and Scholarly InterestsOur medical education research group is developing and validating the best educational practices to train competent, compassionate, and ethical physicians and physician-scientists. We are studying the use of standardized patients and other modalities to improve clinical skill training and reasoning. We are interested in applying the rigor of clinical investigation to education research.
My areas of clinical interest in endocrinology include disorders of the pituitary, thyroid, and gonad. -
Olivier Gevaert
Associate Professor of Medicine (Computational Medicine) and of Biomedical Data Science
Current Research and Scholarly InterestsMy lab focuses on biomedical data fusion: the development of machine learning methods for biomedical decision support using multi-scale biomedical data. We primarily use methods based on regularized linear regression to accomplish this. We primarily focus on applications in oncology and neuroscience.
-
Ishita Ghai
Postdoctoral Scholar, General Internal Medicine
BioIshita Ghai is a health policy researcher that applies causal inference methods to understand how health behaviors are shaped through individual and group factors in low-resource settings. She mainly studies these empirical questions in the context of randomized controlled trials, or through evaluations leveraging exogenous shocks using quasi-experimental techniques. She has managed several pilot and large randomized controlled trials across sub-Saharan Africa studying the short and long-term effects of health interventions on health outcomes for women, children, and people living with HIV/AIDS. At Stanford, she will advance work on medicine policy specifically focused on the effects of the shingles vaccine on dementia risk among older populations.
She completed her doctoral studies in policy analysis (economics concentration) at the RAND School of Public Policy, and holds an MBA from the University of California, Davis, an Ed.M. in international education policy from Harvard University, and a B.Tech in bioinformatics from VIT University. -
Marc Ghanem
Postdoctoral Scholar, Anesthesiology, Perioperative and Pain Medicine
Current Research and Scholarly InterestsMarc's research focuses on leveraging deep learning to identify clinically relevant patterns within large medical datasets, aiming to deliver personalized and predictive healthcare solutions. Current projects include building comprehensive perioperative foundation model, optimizing neonatal total parenteral nutrition (TPN), analyzing anesthesiology research trends, and identifying differential responders and their characteristics in clinical trials.
-
Pejman Ghanouni, MD, PhD
Professor of Radiology (Body MRI) and, by courtesy, of Neurosurgery, of Obstetrics and Gynecology and of Urology
BioDr. Ghanouni is a board-certified, fellowship-trained diagnostic radiologist with Stanford Health Care Radiology. He is an associate professor in the Department of Radiology, Division of Body MRI at Stanford University School of Medicine, and by courtesy, of Urology, of Neurosurgery, and of Obstetrics and Gynecology.
Dr. Ghanouni is the director of the Stanford Health Care Minimally Invasive MR Interventional Center (MIMRIC) and the Focused Ultrasound Center of Excellence. He is also chief of the Division of Body MRI at Stanford University School of Medicine.
Dr. Ghanouni is recognized around the world for his extensive expertise in using advanced imaging to diagnose, manage, and treat a wide range of conditions and disorders. As a renowned leader in diagnostic and MRI-guided interventional radiology, Dr. Ghanouni creates a customized care plan for each of his patients.
Dr. Ghanouni’s research interests include the latest advances in MR-guided focused ultrasound techniques to treat essential tremor, Parkinson’s disease, prostate cancer, bone tumors, desmoid tumors, and uterine fibroids. An experienced physician-scientist, Dr. Ghanouni has collaboratively led clinical trials and research initiatives that explore treatments for epilepsy, pancreatic cancer, and several types of tumors. Through these clinical trials, Dr. Ghanouni has helped secure FDA approval for many MR-guided focused ultrasound treatments.
His articles have been published in dozens of peer-reviewed medical journals, including Lancet Oncology, Neurology, Investigative Radiology, European Radiology, Journal of Magnetic Resonance Imaging, Journal of Neurosurgery, New England Journal of Medicine, and Radiology. Dr. Ghanouni has been invited to speak at conferences and symposiums all over the nation and the world, including in Rome, Italy; Tel Aviv, Israel; and Riyadh, Saudi Arabia. He is widely regarded for his groundbreaking research as well as his clinical expertise.
Dr. Ghanouni is a member of several professional organizations, including the International Society for Magnetic Resonance in Medicine, the International Society for Therapeutic Ultrasound, and the European Focused Ultrasound Society.
MR-guided focused ultrasound treatment: https://www.youtube.com/watch?v=3Bwq2YxD9eU
